Investigating how human rhinovirus infection affects susceptibility to COVID-19
Human rhinovirus infection and susceptibility to SARS-CoV-2 infection and symptomatic disease
This study is looking into why kids usually get milder COVID-19 symptoms than adults, and it’s especially interested in how infections from a common cold virus might help their immune systems fight off COVID-19 better.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Vanderbilt University Medical Center NIH-funded |
| Lab location | 1 site (Nashville, United States) |
| Project ID | NIH-10891725 on NIH RePORTER |
What this research studies
This research explores why children often have milder COVID-19 symptoms compared to adults, focusing on the role of human rhinovirus (HRV) infections. The study will analyze real-world data to understand how HRV may influence the immune response to SARS-CoV-2, potentially reducing the severity of COVID-19. By examining the sequence of infections and clinical features in individuals, the research aims to provide insights into the protective effects of HRV against COVID-19. Participants will be monitored for their infection history and immune responses.
Who could benefit from this research
Good fit: Ideal candidates for this research include children and adults who have experienced HRV infections and are at risk for COVID-19.
Not a fit: Patients who have not had HRV infections or those who are not at risk for COVID-19 may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new strategies for preventing severe COVID-19 infections, particularly in vulnerable populations like children.
How similar studies have performed: Previous studies have suggested that HRV infections may provide some protective effects against other respiratory viruses, indicating potential for success in this novel approach.
Where this research is happening
Nashville, United States
- Vanderbilt University Medical Center — Nashville, United States (Active)
Researchers
- Principal investigator: Howard, Leigh Meredith — Vanderbilt University Medical Center
- Study coordinator: Howard, Leigh Meredith
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.